Study of effects of selenium supplement in thyroid eye disease patients, A double-blind, randomized controlled trial

Office of Research and Development0 个研究点目标入组 100 人开始时间: 2022年7月25日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Patient aged 20 years or more who was diagnosed with thyroid disease and received the treatment no longer than 3 months
•1.1 Thyroid diseases includes hyperthyroidism, hypothyroidism and autoimmune thyroid or
•1.2 Patients who diagnosed with thyroid disease and have euthyroid status
•2. Healthy participants aged 20 years or more
•2.1 No history of thyroid disease
•2.2 No status of malnutrition

•1. Patients who received thyroid surgery
•2. Patients who received radiotherapy
•3. Patients who have lived in Thailand less than a year
•4. Patients who have serious illness (e.g. cancer, acute infection)
•5. Patient who have severe thyroid eye disease and the treatment by steroid, radiotherapy, or orbital surgery are needed or planned
•6. Patient who have selenium level more than 400 micrograms/liter
•7. Patient with chronic kidney disease
•8. Pregnant

发起方

Office of Research and Development